p776

General Information


DCTPep ID  DCTPep00317

Peptide Name   p776

Sequence  GVGSPYVSRLLGICL

Sequence Length  15

UniProt ID  P04626  O18735  P06494  P70424 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Disrupting tumor-mediated mechanisms suppressing host immunity



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep00317

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C69H116N18O19S1

Absent amino acids  ADEFHKMNQTW

Theoretical pI  8.22

Acidic residues  0

Basic residues  1

Polar residues  7

Molecular weight (Average)  1533.85

Molecular weight (Monoisotopic)  1532.84

Common amino acids  GL

Net charge  1

Instability index (II)  52.99

Aliphatic index  142.67

Grand average of hydropathicity (GRAVY)  1.107

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 1490
  Abs 0.1% (=1 g/l) 0.971, assuming all pairs of Cys residues form cystines
  Ext. coefficient 1490
  Abs 0.1% (=1 g/l) 0.971, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21928125

Title  Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice

Doi 10.1007/s00262-011-1113-4

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.